483 related articles for article (PubMed ID: 33468665)
21. Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2.
Ngubo M; Moradi F; Ito CY; Stanford WL
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895228
[TBL] [Abstract][Full Text] [Related]
22. Histone methylation by PRC2 is inhibited by active chromatin marks.
Schmitges FW; Prusty AB; Faty M; Stützer A; Lingaraju GM; Aiwazian J; Sack R; Hess D; Li L; Zhou S; Bunker RD; Wirth U; Bouwmeester T; Bauer A; Ly-Hartig N; Zhao K; Chan H; Gu J; Gut H; Fischle W; Müller J; Thomä NH
Mol Cell; 2011 May; 42(3):330-41. PubMed ID: 21549310
[TBL] [Abstract][Full Text] [Related]
23. Interdependence of PRC1 and PRC2 for recruitment to Polycomb Response Elements.
Kahn TG; Dorafshan E; Schultheis D; Zare A; Stenberg P; Reim I; Pirrotta V; Schwartz YB
Nucleic Acids Res; 2016 Dec; 44(21):10132-10149. PubMed ID: 27557709
[TBL] [Abstract][Full Text] [Related]
24. Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction.
Guo Y; Zhao S; Wang GG
Trends Genet; 2021 Jun; 37(6):547-565. PubMed ID: 33494958
[TBL] [Abstract][Full Text] [Related]
25. RYBP stimulates PRC1 to shape chromatin-based communication between Polycomb repressive complexes.
Rose NR; King HW; Blackledge NP; Fursova NA; Ember KJ; Fischer R; Kessler BM; Klose RJ
Elife; 2016 Oct; 5():. PubMed ID: 27705745
[TBL] [Abstract][Full Text] [Related]
26. Polycomb Repressive Complex 2 in Oncology.
Guo Y; Yu Y; Wang GG
Cancer Treat Res; 2023; 190():273-320. PubMed ID: 38113005
[TBL] [Abstract][Full Text] [Related]
27. PRC2.1- and PRC2.2-specific accessory proteins drive recruitment of different forms of canonical PRC1.
Glancy E; Wang C; Tuck E; Healy E; Amato S; Neikes HK; Mariani A; Mucha M; Vermeulen M; Pasini D; Bracken AP
Mol Cell; 2023 May; 83(9):1393-1411.e7. PubMed ID: 37030288
[TBL] [Abstract][Full Text] [Related]
28. PRC2.1 and PRC2.2 Synergize to Coordinate H3K27 Trimethylation.
Healy E; Mucha M; Glancy E; Fitzpatrick DJ; Conway E; Neikes HK; Monger C; Van Mierlo G; Baltissen MP; Koseki Y; Vermeulen M; Koseki H; Bracken AP
Mol Cell; 2019 Nov; 76(3):437-452.e6. PubMed ID: 31521505
[TBL] [Abstract][Full Text] [Related]
29. Polycomb-mediated gene silencing by the BAH-EMF1 complex in plants.
Li Z; Fu X; Wang Y; Liu R; He Y
Nat Genet; 2018 Sep; 50(9):1254-1261. PubMed ID: 30082786
[TBL] [Abstract][Full Text] [Related]
30. An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting.
Cai L; Rothbart SB; Lu R; Xu B; Chen WY; Tripathy A; Rockowitz S; Zheng D; Patel DJ; Allis CD; Strahl BD; Song J; Wang GG
Mol Cell; 2013 Feb; 49(3):571-82. PubMed ID: 23273982
[TBL] [Abstract][Full Text] [Related]
31. PICOT binding to the polycomb group protein, EED, alters H3K27 methylation at the MYT1 PRC2 target gene.
Pandya P; Pasvolsky R; Babichev Y; Braiman A; Witte S; Altman A; Isakov N
Biochem Biophys Res Commun; 2019 Feb; 509(2):469-475. PubMed ID: 30595380
[TBL] [Abstract][Full Text] [Related]
32. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression.
Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M
J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide redistribution of H3K27me3 is linked to genotoxic stress and defective growth.
Basenko EY; Sasaki T; Ji L; Prybol CJ; Burckhardt RM; Schmitz RJ; Lewis ZA
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6339-48. PubMed ID: 26578794
[TBL] [Abstract][Full Text] [Related]
34. A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin.
Chen S; Jiao L; Liu X; Yang X; Liu X
Mol Cell; 2020 Mar; 77(6):1265-1278.e7. PubMed ID: 31959557
[TBL] [Abstract][Full Text] [Related]
35. Structural insights into the interactions of Polycomb Repressive Complex 2 with chromatin.
Iragavarapu AG; Yao L; Kasinath V
Biochem Soc Trans; 2021 Dec; 49(6):2639-2653. PubMed ID: 34747969
[TBL] [Abstract][Full Text] [Related]
36. Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity.
Lavarone E; Barbieri CM; Pasini D
Nat Commun; 2019 Apr; 10(1):1679. PubMed ID: 30976011
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of facultative heterochromatin and polycomb group protein association with the herpes simplex viral genome during establishment of latent infection.
Cliffe AR; Coen DM; Knipe DM
mBio; 2013 Jan; 4(1):. PubMed ID: 23322639
[TBL] [Abstract][Full Text] [Related]
38. Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation.
Laugesen A; Højfeldt JW; Helin K
Mol Cell; 2019 Apr; 74(1):8-18. PubMed ID: 30951652
[TBL] [Abstract][Full Text] [Related]
39. Alternative splicing decouples local from global PRC2 activity.
Arecco N; Mocavini I; Blanco E; Ballaré C; Libman E; Bonnal S; Irimia M; Di Croce L
Mol Cell; 2024 Mar; 84(6):1049-1061.e8. PubMed ID: 38452766
[TBL] [Abstract][Full Text] [Related]
40. PRC2-independent chromatin compaction and transcriptional repression in cancer.
Vallot C; Hérault A; Boyle S; Bickmore WA; Radvanyi F
Oncogene; 2015 Feb; 34(6):741-51. PubMed ID: 24469045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
